Blood Gas Analyzer Market Share

North American Market Forecasts

The blood gas analyzer market in the North American region is anticipated to grow at a revenue share of 80% by the end of 2037. In this region, the opportunities for companies in blood gas analyzers are projected to be very attractive due to increasing healthcare costs and the swift uptake of new technology. The importance of this market in the United States is driven by improved networks between multidisciplinary hospitals, insurance companies, and medical device manufacturers. For example, the United States Food and Drug Administration approved the Siemens Healthineers RAPIDPoint 500e Blood Gas Analyzer, used in critical care, in March 2020.

European Market Statistics

The blood gas analyzer market is estimated to hold a significant revenue share during the projected period. In particular, due to the increasing demand from larger, medium, and smaller hospitals in Europe's main countries for automated analyzers capable of fast multiparameter testing, Europe continues to grow. More diagnostics are being performed as a result of an increase in healthcare infrastructure and availability. The need for high throughput blood gas analyzers to efficiently manage workload is driven by this requirement. Up to 120 tests an hour can be performed with high precision by the majority of today's tools.